Author: André Serradimigni
Publisher: S. Karger AG (Switzerland)
ISBN:
Category : Medical
Languages : en
Pages : 172
Book Description
International Conference on Thrombolysis
Author: André Serradimigni
Publisher: S. Karger AG (Switzerland)
ISBN:
Category : Medical
Languages : en
Pages : 172
Book Description
Publisher: S. Karger AG (Switzerland)
ISBN:
Category : Medical
Languages : en
Pages : 172
Book Description
Current Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1068
Book Description
First multi-year cumulation covers six years: 1965-70.
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1068
Book Description
First multi-year cumulation covers six years: 1965-70.
Proceedings of the Second International Conference on Synthetic Fibrinolytic-Thrombolytic Agents
Author: John Forsyth Davidson
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 466
Book Description
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 466
Book Description
National Library of Medicine Current Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 762
Book Description
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 762
Book Description
Index of NLM Serial Titles
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1584
Book Description
A keyword listing of serial titles currently received by the National Library of Medicine.
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1584
Book Description
A keyword listing of serial titles currently received by the National Library of Medicine.
Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society: Biophysical and biochemical measurements. Sensors, lasers and electrooptics. Molecular electronics. Instrumentation. Critical care monitoring. Rehabilitation engineering. Speech, hearing, and vision aids
Author: IEEE Engineering in Medicine and Biology Society. Conference
Publisher:
ISBN:
Category : Biomedical engineering
Languages : en
Pages : 520
Book Description
Publisher:
ISBN:
Category : Biomedical engineering
Languages : en
Pages : 520
Book Description
Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society
Author: IEEE Engineering in Medicine and Biology Society. Annual Conference
Publisher:
ISBN:
Category : Biomedical engineering
Languages : en
Pages : 520
Book Description
Publisher:
ISBN:
Category : Biomedical engineering
Languages : en
Pages : 520
Book Description
Proceedings of the 18th Annual International Conference of the IEEE Engineering in Medicine and Biology Society
Author: IEEE Engineering in Medicine and Biology Society. Annual Conference
Publisher:
ISBN:
Category : Biomedical engineering
Languages : en
Pages : 526
Book Description
Publisher:
ISBN:
Category : Biomedical engineering
Languages : en
Pages : 526
Book Description
Cumulated Index Medicus
Author:
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 872
Book Description
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 872
Book Description
Fibrinolytics and Antifibrinolytics
Author: Fritz Markwardt
Publisher: Springer Science & Business Media
ISBN: 3642668631
Category : Medical
Languages : en
Pages : 663
Book Description
Disturbances of haemostasis and thromboembolic disorders still constitute a great problem in clinical practice. Increasing insight into the mechanism of blood coagula tion has led to more effective therapy and prophylaxis. Particularly, the understand ing of the biochemistry of fibrinolysis has provided possibilities for the pharma cological interference of these processes, which has resulted in effective haemostatic agents and useful antithrombotic ones. The development of antifibrinolytics for interfering with pathological fibrinolytic processes is nearly complete and has led to the development of drugs essential to the therapy of hyperfibrinolytic bleeding. The search for fibrinolytics for dissolving intravascular thrombi has led to highly effective compounds. This development is still under way and promising results are hoped. Spontaneous dissolution of blood clots is a phenomenon which was described a century ago. First investigations of this process assured that there is in the organism a system capable of removing the fibrin which is formed during blood coagulation after it has fulfilled its physiological function. This fibrinolytic system is specifically adapted to the degradation of insoluble fibrin into soluble degradation products. In the past 30 years, thorough investigation of this system has clarified the fibrinolytic process, its physiological role and its meaning as a pathogenetic principle. A good knowledge of these processes is required for an understanding of the effects and side effects of fibrinolytics and antifibrinolytics, which comprise the basis of methods for the detection of fibrinolytic processes in the organism and of the control of therapy with these drugs.
Publisher: Springer Science & Business Media
ISBN: 3642668631
Category : Medical
Languages : en
Pages : 663
Book Description
Disturbances of haemostasis and thromboembolic disorders still constitute a great problem in clinical practice. Increasing insight into the mechanism of blood coagula tion has led to more effective therapy and prophylaxis. Particularly, the understand ing of the biochemistry of fibrinolysis has provided possibilities for the pharma cological interference of these processes, which has resulted in effective haemostatic agents and useful antithrombotic ones. The development of antifibrinolytics for interfering with pathological fibrinolytic processes is nearly complete and has led to the development of drugs essential to the therapy of hyperfibrinolytic bleeding. The search for fibrinolytics for dissolving intravascular thrombi has led to highly effective compounds. This development is still under way and promising results are hoped. Spontaneous dissolution of blood clots is a phenomenon which was described a century ago. First investigations of this process assured that there is in the organism a system capable of removing the fibrin which is formed during blood coagulation after it has fulfilled its physiological function. This fibrinolytic system is specifically adapted to the degradation of insoluble fibrin into soluble degradation products. In the past 30 years, thorough investigation of this system has clarified the fibrinolytic process, its physiological role and its meaning as a pathogenetic principle. A good knowledge of these processes is required for an understanding of the effects and side effects of fibrinolytics and antifibrinolytics, which comprise the basis of methods for the detection of fibrinolytic processes in the organism and of the control of therapy with these drugs.